We demonstrated that the expression of the plasminogen receptor S100A10 was driven by oncogenic KRASG12D which contributed to the enhancement of plasmin generation by pancreatic cancer cells (Fig. 6C,J; Fig. S14). Here, S100A10 is linked to pancreatic neoplasm.